Bezafibrate Enhances AAV Gene Therapy in Glycogen Storage Disease Type Ia
Publication
, Conference
Kang, HR; Waskowicz, L; Koeberl, DD
Published in: MOLECULAR THERAPY
May 1, 2018
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2018
Volume
26
Issue
5
Start / End Page
447 / 447
Location
Chicago, IL
Publisher
CELL PRESS
Conference Name
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kang, H. R., Waskowicz, L., & Koeberl, D. D. (2018). Bezafibrate Enhances AAV Gene Therapy in Glycogen Storage Disease Type Ia. In MOLECULAR THERAPY (Vol. 26, pp. 447–447). Chicago, IL: CELL PRESS.
Kang, Hye Ri, Lauren Waskowicz, and Dwight D. Koeberl. “Bezafibrate Enhances AAV Gene Therapy in Glycogen Storage Disease Type Ia.” In MOLECULAR THERAPY, 26:447–447. CELL PRESS, 2018.
Kang HR, Waskowicz L, Koeberl DD. Bezafibrate Enhances AAV Gene Therapy in Glycogen Storage Disease Type Ia. In: MOLECULAR THERAPY. CELL PRESS; 2018. p. 447–447.
Kang, Hye Ri, et al. “Bezafibrate Enhances AAV Gene Therapy in Glycogen Storage Disease Type Ia.” MOLECULAR THERAPY, vol. 26, no. 5, CELL PRESS, 2018, pp. 447–447.
Kang HR, Waskowicz L, Koeberl DD. Bezafibrate Enhances AAV Gene Therapy in Glycogen Storage Disease Type Ia. MOLECULAR THERAPY. CELL PRESS; 2018. p. 447–447.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2018
Volume
26
Issue
5
Start / End Page
447 / 447
Location
Chicago, IL
Publisher
CELL PRESS
Conference Name
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences